DMK Pharmaceuticals Corp
SEC CIK 887247 · DMK · last insider filing 2023-11-02
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Versi Ebrahim | Director · CEO | filed 2023 - 2023 |
| Desai Meera J. | Director | filed 2021 - 2023 |
| Versi Jannine | Director | filed 2023 - 2023 |
| Birndorf Howard C | Director | filed 2019 - 2022 |
| Carlo Dennis J PHD | Director · President/CEO | filed 2009 - 2022 |
| Reed Vickie S | Director | filed 2022 - 2022 |
| Marguglio David J. | Director · VP/Bus. Dev. & Inv. Relations | filed 2009 - 2022 |
| Blunt Roshawn A. | Director | filed 2019 - 2020 |
| Williams Richard C | Director · CEO | filed 2006 - 2019 |
| Rothermel Robert B | Director | filed 2006 - 2019 |
| Denby William C | Director | filed 2014 - 2019 |
| Nova Tina Susan | Director | filed 2011 - 2013 |
| Cohen Kenneth M | Director | filed 2011 - 2013 |
| Johnson Craig A | Director | filed 2011 - 2013 |
| Aloi Richard L | Director | filed 2009 - 2009 |
| Adams John Q | Director | filed 2006 - 2009 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Dorbin John W. Jr. | General Counsel | filed 2023 - 2023 |
| Cohen Seth | CFO | filed 2023 - 2023 |
| Moss Ronald B. | Chief Medical Officer | filed 2017 - 2022 |
| Benedicto David C. | Principal Accounting Officer | filed 2021 - 2022 |
| Hopkins Robert O | Chief Financial Officer | filed 2009 - 2021 |
| Daniels Karen K. | Vice President of Operations | filed 2011 - 2021 |
| Glover Eddie Wabern | CEO of US Compounding, Inc. | filed 2016 - 2019 |
| Moll Thomas | Vice President of Research | filed 2011 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.